NEU 0.00% $19.97 neuren pharmaceuticals limited

Media News, page-141

  1. 2,166 Posts.
    lightbulb Created with Sketch. 571
    PME is a great comparison for the non believers.

    We could have that type of revenue FY2024 from US sales alone, not to mention we will likely have more cash on hand also.

    From US deal alone Neu in FY 25,26,27 and on, dwarfs PME's revenue.

    Then bolt on ROW once we know the actual out come.

    Using PME as a comparison we could be valued at $120+p/sh on DAYBUE alone $12bn market cap approx

    For Neu $60 p/sh or $6bn market cap is a good starting point.

    Then 2591 could add some value also.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.97
Change
0.000(0.00%)
Mkt cap ! $2.552B
Open High Low Value Volume
$19.96 $19.97 $19.69 $4.156M 209.6K

Buyers (Bids)

No. Vol. Price($)
1 246 $19.88
 

Sellers (Offers)

Price($) Vol. No.
$19.99 512 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.